financial overview for the first quarter of fiscal … › english › ir › overview › pdf ›...
TRANSCRIPT
0
Financial Overview for the First Quarter of Fiscal Year Ending
December 31, 2020 (January 1, 2020 to March 31, 2020)
April 28, 2020
111/15Summary of Financial Results Net sales increased year-on-year (100.7% of the previous year). Operating income decreased year-on-year (94.7% of the previous year).
However, the decrease was attributable to the change of the depreciation method for and change in service life of property, plant and equipment (down 0.74 billion yen). If such negative impact is excluded, operating income grew year-on-year, 109.1% of the previous year in real terms.
Main factors for changes in net sales(1) Spread of new coronavirus infections (impact on the Domestic Business)
• Increase in demand mainly for disinfectant products and sanitary products (up 1.7 billion yen)
• Decrease in inbound demand (down 1.1 billion yen)(2) Spread of new coronavirus infections (impact on the International Business)
• Increase in demand for Netsusama Sheet and Glasses Cleaner in each country (up 0.2 billion yen)
• Sluggish sales at stores in China (down 0.2 billion yen)• Steady sales in Mainland China EC (up 0.1 billion yen)
(3) Poor sales of body warmers overseas due to mild winter (down 0.5 billion yen)
(4) Uphill battle in the Direct Marketing Business (down 0.2 billion yen)
222/15
Results for Jan. to Mar. 2020 Results for Jan. to Mar.
2019 *2Published results In real terms*1
Amount
(million yen)
Margin
(%)
Percentage
(%)
Amount
(million yen)
Margin
(%)
Percentage
(%)
Amount
(million yen)
Net sales 31,911 – 100.7% 31,911 – 100.7% 31,677
Operating
income4,875 15.3% 94.7% 5,618 17.6% 109.1% 5,149
Ordinary
income5,042 15.8% 96.6% 5,788 18.1% 110.9% 5,219
Net income 3,742 11.7% 101.6% 4,251 13.3% 115.4% 3,683
Consolidated Financial Results for the First Quarter
of Fiscal Year Ending December 31, 2020
*1: Figures after excluding the impact of full amortization due to the change in service life of and change of depreciation method
for property, plant and equipment
*2: The Accounting Standard for Revenue Recognition has been applied from FY2020. For comparison purposes, results for
FY2019 were prepared based on the new standard.
333/15Changes in Consolidated Net Sales and
Gross Profit Ratio
226 234
226
266 258
268
290
316 316 319
58.1 57.9
55.1
51.853.4 53.1
59.0 59.0 59.057.1
50.0
55.0
60.0
65.0
70.0
75.0
80.0
85.0
90.0
150
170
190
210
230
250
270
290
310
330
350
Jan. toMar.2011
Jan. toMar.2012
Jan. toMar.2013
Jan. toMar.2014
Jan. toMar.2015
Jan. toMar.2016
Jan. toMar.2017
Jan. toMar.2018
Jan. toMar.2019
Jan. toMar.2020
Net sales
Gross profit ratio
(Unit: 100 million yen)
(Unit: %)
59.1% in real terms,
excluding the impact
of full amortization
444/15
25
18
25
19 19
13
48
54 51
48
11.37.9
11.17.3 7.5
5.0
16.6 17.1 16.3 15.3
0.0
5.0
10.0
15.0
20.0
25.0
30.0
35.0
40.0
45.0
50.0
55.0
60.0
65.0
70.0
0
10
20
30
40
50
60
Jan. toMar.2011
Jan. toMar.2012
Jan. toMar.2013
Jan. toMar.2014
Jan. toMar.2015
Jan. toMar.2016
Jan. toMar.2017
Jan. toMar.2018
Jan. toMar.2019
Jan. toMar.2020
Operating income
Operating margin
Changes in Operating Income and Operating Margin
(Unit: 100 million yen)
(Unit: %)
17.6% in real terms,
excluding the impact
of full amortization
Operating income in real terms, excluding the impact of full amortization 56
555/15
51.4
48.7
+1.6
+2.7+1.0
0.5 0.51.1
1.6
7.4
+1.5 +0.3 +0.5
0.3 0.5
+1.6
Op
erat
ing
inco
me
for
Jan
. to
Mar
. 201
9
Sal
es in
crea
se
Co
st r
edu
ctio
n
Fix
ed c
ost
s
Ch
ang
e in
pro
du
ct m
ix
Incr
ease
in r
aw m
ater
ial
pri
ces
Lo
ss o
n d
isp
osa
l of
inve
nto
ry
Oth
er c
ost
s
Imp
act
of
the
chan
ge
of
the
dep
reci
atio
n m
eth
od
Sal
es p
rom
oti
on
exp
ense
s
Co
mm
issi
on
s p
aid
Per
son
nel
co
sts
Ad
vert
isin
g e
xpen
ses
Ph
ysic
al d
istr
ibu
tio
nco
sts
Oth
er e
xpen
ses
Op
erat
ing
inco
me
for
Jan
. to
Mar
. 202
0
56.1
Factors for Changes in Consolidated Operating Income
- - - Factor for increase
- - - Factor for decrease
Production costs SGA expenses
(Unit: 100 million yen)
Operating income decreased by 740 million yen (production costs: 630 million yen, SGA expenses:
110 million yen) due to full amortization at the beginning of the fiscal term in association with the
change of the depreciation method and shortening of service life. Operating income stood at
109.1% of the previous year in real terms, excluding the impact of full amortization.
Year-on-year
percentage
94.7%
Year-on-year percentage
in real terms
109.1%
Impact of production costs: 6.3
Impact of SGA expenses: 1.1
666/15
Net sales Operating incomeFactors for changes
Amount
(million yen)
Percentage
(%)
Amount
(million yen)
Percentage
(%)
Domestic
Business24,774 104.5% 4,381 103.2%
+ Sanitary products (+0.8 billion yen)
+ Household articles (+0.2 billion yen)
+ Skin care products (+0.1 billion yen)
Pharmaceuticals (0.1 billion yen)
Food (0.1 billion yen)
International
Business4,763 91.0% 362 51.2%
+ Australia (+0.1 billion yen)
China and Hong Kong (0.2 billion
yen)
Taiwan (0.1 billion yen)
U.K. (0.1 billion yen)
Direct
Marketing
Business2,170 89.0% 16 -
Financial Results for the First Quarter of FY2020 by Segment
Sales in the Domestic Business increased due to a rise in demand related to the spread of new
coronavirus infections. However, sales in the International Business decreased due to sluggish
sales of body warmers caused by the mild winter.
777/15Domestic Business (Impact of Spread of New Coronavirus Infections)
Around the middle of January, demand increased for disinfectant and sanitary products,
mainly masks. However, demand for some products decreased in March in reaction to
the rise in the preceding months. Net sales grew by 1.7 billion yen.
Ranking ItemPercentage
(%)
1 Nodonool Nure Mask 142%
2 Nodonool Spray 153%
3 Netsusama Sheet 129%
4 Sarasaty 118%
5 Ekitai Bluelet Jokin 128%
6 Hananoa 132%
7 Glasses Cleaner 146%
8 Eau de Muge 129%
9 Eyebon 107%
10 Dusmock 136%
11 Kantansenjomaru 122%
12 Toilet Seat Disinfectant Cleaner 156%
13 Sneaker Mist 129%
14 Sabotta Ring 135%
15 Nightmin Nasal Respiration Tape 108%
<Ranking by sales growth rate>Jan. to Mar. 2020
* The effectiveness of these disinfectant and sanitary products against the new coronavirus has not been proved yet.
888/15
<Estimated inbound-related sales>
Inbound-related sales decreased to 1.1 billion yen due to a fall in the number of
foreign visitors to Japan. (Jan.: 97% of 2019, Feb.: 41% of 2019, Mar.: 19% of
2019)
Ranking Item Percentage (%)
1 Nodonool Spray 85%
2 Inochi no Haha 37%
3 Ammeltz 67%
4 SakamuCare 38%
5 Nodonool Nure Mask 123%
6 BreathCare 30%
7 Eyebon 36%
8 Glasses Cleaner 61%
9 Harenurse 54%
10 Nattokinase 45%
<Sales ranking by brand>Jan. to Mar. 2020
Domestic Business (Inbound Demand)
7 10
13
23 22
11
2.74.1 4.4
7.3 7.0
3.4
0.0
5.0
10.0
15.0
20.0
25.0
30.0
0
25
Jan. toMar. 2015
Jan. toMar. 2016
Jan. toMar. 2017
Jan. toMar. 2018
Jan. toMar. 2019
Jan. toMar. 2020
Net sales
Sales ratio
(Unit: 100 million yen)
(Unit: %)
999/15Domestic Business (Sales Breakdown by Business Category)
Sales of healthcare products were sluggish due to a fall in inbound-related sales.Sales of household products grew sharply due to a rise in demand related to the spread of new coronavirus infections.Sales of body warmers remained weak due to the mild winter, but the extent of the decrease became smaller owing to the reduction of returns.
Net salesResults for Jan. to Mar. 2020
Results for Jan.
to Mar. 2019 *1
Amount
(million yen)Percentage (%)
Amount
(million yen)
Healthcare products 12,316 98.1% 12,558
Household products 10,457 113.4% 9,224
Skin care products 1,540 105.8% 1,456
Body warmers 459 96.9% 473
Total 24,774 104.5% 23,712
*1: The Accounting Standard for Revenue Recognition has been applied from FY2020. For comparison purposes,
results for FY2019 were prepared based on the new standard.
101010/15International Business(Sales Breakdown by Region)
In each country, demand for Netsusama Sheet and Glasses Cleaner increased due to the spread
of new coronavirus infections. However, overall sales decreased from the previous year because
of sluggish sales of body warmers due to the mild winter.
Net salesResults for Jan. to Mar. 2020
Results for Jan. to
Mar. 2019 *1
Amount
(million yen)Percentage (%)
Amount
(million yen)
U.S. 1,255 99.2% 1,265
China (mainland) 1,396 92.4% 1,510
(Hong Kong) 401 75.3% 533
Southeast Asia 1,078 82.6% 1,305
Other 631 102.1% 619
Total 4,763 91.0% 5,233*1: The Accounting Standard for Revenue Recognition has been applied from FY2020. For comparison purposes,
results for FY2019 were prepared based on the new standard.
111111/15
3.1
1.5 1.7
3.1
1.6
3.0
Jan. Feb. Mar.
FY2019 FY2020
Overall sales were sluggish due to the restriction on travel and stagnation of the distribution network
caused by the spread of new coronavirus infections. In particular, sales via stores plunged since the
number of closed stores increased. Meanwhile, sales via EC grew sharply in March, although sales
growth remained moderate in January and February since product distribution was paralyzed.
Chinese Business (Stores and EC)
5.3
1.02.2
4.3
0.7 1.1
Jan. Feb. Mar.
FY2019 FY2020
<Sales via stores> <Sales via EC (Mainland and Cross-border)>(Unit: 100 million yen) (Unit: 100 million yen)
8.6
6.2
Jan. to Mar.
Sales by month Total
6.47.7
Jan. to Mar.
Sales by month Total
121212/15
Sales of body warmers and Netsusama Sheet, which are sold mainly via stores, decreased from
the previous year. Sales of Netsusama Sheet were also affected by the temporary restriction of
sales via pharmacies (*). Sluggish sales of body warmers were due to the mild winter. Meanwhile,
other products, which are mainly marketed via EC, grew sharply.
5.2 5.3 4.5
3.1 4.1
6.6
カイロ 熱さまシート その他日用品FY2019 FY2020
<Net sales (Jan. to Mar.)>(Unit: 100 million yen)
Percentage
(%)
145%
Percentage
(%)
78%
Percentage
(%)
61%
FY2019 FY2020
Body warmers Netsusama Sheet Other
Chinese Business (by Item)
* The government restricted sales of “goods that lower body temperature” via pharmacies. Netsusama Sheet was included in
the goods. The government aimed to prevent the spread of new coronavirus infections by restricting the use of over-the-
counter medicines, etc. that help to lower body temperature and cure a disease without going to see a doctor.
FY2019 FY2020
131313/15Chinese Business (Boosting the Business)
In FY2019, sales increased greatly since we aggressively promoted sales of BreathCare
and Shoshugen. In China, we will try not only to increase the selection of these products
but also to market new products and new lines of existing products soon after they are
launched in Japan.
<Net sales (Jan. to Dec.)>
2.8
0.4 0.4
5.2
2.0 2.9
ランジェリー洗剤 ブレスケア その他日用品
(Unit: 100 million yen)
FY2018 FY2019 FY2018 FY2019 FY2018 FY2019
Detergents for lingerie
1.8 times
BreathCare Shoshugen
5 times 7 times
141414/15Forecast of Consolidated Results for Year Ending December 2020
We have not changed our forecast of consolidated results for the year ending
December 2020 that was announced at the beginning of FY2020 since it is difficult for
us to predict how long the new coronavirus outbreak will last at the present moment.
FY2020 forecast (Jan. to Dec. 2020)
FY2019 results
(Jan. to Dec. 2019)
(under new standards)
Amount
(million yen)Margin (%) Percentage (%)
Amount
(million yen)
Net sales 165,000 – 104.2% 158,318
Operating
income26,400 16.0% 102.9% 25,658
Ordinary income 28,000 17.0% 100.5% 27,851
Net income 20,000 12.1% 104.5% 19,139
EPS 255.88 yen – 104.8% 244.08 yen
ROE 11.3% – – 11.3%
151515/15
Net sales
Amount
(million yen)
Percentage
(%)
Domestic
Business 127,600 103.7%
International
Business 26,200 107.5%
Direct Marketing
Business 10,000 102.4%
Forecast of Consolidated Results for Year Ending December 2020
16
<Note>
Of the Company’s current business performance, plans, and strategies included in this
material, items that are not historical facts are outlooks on future performance, which are
based on the judgment of the Company’s management according to currently available
information. Therefore, please note that actual performance may differ significantly from
the future outlook described in this material due to changes in various factors.
17
Reference
1818
(Unit: 100 million yen)Jan. to Mar.
2020
Percentage
(%)
Jan. to Mar.
2019
Net sales 319 100.7% 316
Gross profit 182 97.4% 187
Margin 57.1% 59.0%
Operating income 48 94.7% 51
Margin 15.3% 16.3%
Ordinary income 50 96.6% 52
Margin 15.8% 16.5%
Net income 37 101.6% 36
Margin 11.7% 11.6%
Consolidated Income Statement 1
1919
(Unit: 100 million yen) End of Mar. 2020 End of Dec. 2019
Current assets 1,563 1,630
Cash and deposits 793 755
Notes and accounts
receivable-trade411 541
Short-term investment
securities154 149
Inventories 177 153
Non-current assets 655 706
Property, plant and equipment 200 211
Intangible assets 30 31
Investment and other assets 424 463
Total assets 2,218 2,337
Consolidated Balance Sheet (1) 2
2020
(Unit: 100 million yen) End of Mar. 2020 End of Dec. 2019
Current liabilities 458 537
Notes and accounts payable-
trade81 79
Short-term loans payable 0 0
Accounts payable-other 182 241
Non-current liabilities 55 73
Total net assets 1,704 1,726
Capital surplus 41 41
Retained earnings 1,742 1,736
Treasury stock 197 197
Total liabilities and net assets 2,218 2,337
3Consolidated Balance Sheet (2)
2121Results by Segment (Domestic Business)
(Unit: 100 million yen)Jan. to Mar.
2020Percentage (%)
Jan. to Mar.
2019
Net sales 247 104.5% 237
Gross profit 140 100.5% 139
Margin 56.7% 58.9%
Operating income 43 103.2% 42
Margin 17.7% 17.9%
Advertising expenses 29 100.2% 29
Percentage 11.9% 12.4%
Sales promotion
expenses3 109.8% 2
Percentage 1.3% 1.2%
4
2222
Net sales
(Unit: 100 million yen)
Jan. to Mar.
2020
Percentage
(%)
Jan. to Mar.
2019
Healthcare products 123 98.1% 125
Pharmaceuticals 71 98.5% 72
Food 15 90.2% 16
Oral care products 37 100.8% 36
Household products 104 113.4% 92
Sanitary products 35 129.2% 27
Deodorizing air
fresheners57 102.5% 56
Household articles 10 133.8% 8
Skin care products 15 105.8% 14
Body warmers 4 96.9% 4
Results by Segment (Domestic Business) 5
2323Results by Segment (International Business)
(Unit: 100 million yen)Jan. to Mar.
2020Percentage (%)
Jan. to Mar.
2019
Net sales 47 91.0% 52
Gross profit 24 133.0% 27
Margin 50.4% 52.4%
Operating income 3 51.2% 7
Margin 7.6% 13.5%
Advertising expenses 2 86.7% 2
Percentage 5.1% 5.3%
Sales promotion
expenses2 62.0% 3
Percentage 4.5% 6.6%
6
2424
Net sales
(Unit: 100 million yen)Jan. to Mar. 2020 Percentage (%) Jan. to Mar. 2019
U.S. 12.5 99.2% 12.6
China and Hong Kong 17.9 88.0% 20.4
China 13.9 92.4% 15.1
(Stores) 6.2 71.5% 8.6
(Mainland EC) 5.9 120.6% 4.9
(Cross-border EC) 1.8 121.1% 1.5
Hong Kong 4.0 75.3% 5.3
Southeast Asia 10.7 82.6% 13.0
Singapore 0.5 60.5% 0.8
Malaysia 3.7 84.3% 4.4
Thailand 2.5 99.2% 2.5
Indonesia 0.8 112.0% 0.7
Philippines 1.4 94.7% 1.5
Taiwan 1.7 59.0% 3.0
Other 6.3 102.1% 6.1
7Results by Segment (International Business)
2525Results by Segment
(Direct Marketing Business)
(Unit: 100 million yen)Jan. to Mar.
2020Percentage (%)
Jan. to Mar.
2019
Net sales 21 89.0% 24
Gross profit 15 90.3% 16
Margin 70.7% 69.7%
Operating income 0.1 – 0.7
Margin – 3.2%
Advertising expenses 6 107.0% 6
Percentage 31.0% 25.7%
Sales promotion
expenses
1 76.3% 1
Percentage 6.2% 7.3%
8